Ralaniten is a potent and orally active antagonist of the androgen receptor N-terminal domain (AR-NTD). It effectively inhibits AR transcriptional activity, displaying an IC50 of 7.4 μM. Ralaniten is primarily applied in research concerning castration-resistant prostate cancer (CRPC), offering insights into potential therapeutic strategies targeting this condition.
Ralaniten is a potent and orally active antagonist of the androgen receptor N-terminal domain (AR-NTD). It effectively inhibits AR transcriptional activity, displaying an IC50 of 7.4 μM. Ralaniten is primarily applied in research concerning castration-resistant prostate cancer (CRPC), offering insights into potential therapeutic strategies targeting this condition.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
